◼ Archived
Business
🔮 fades ✓
Insilico's co-CEO hopes 'we might have a chance to stop biological aging'
Recent coverage explores potential links between a lung disease drug and the slowing of biological aging.
2 trends tracked about this subject — the full history, oldest to newest below.
Recent coverage explores potential links between a lung disease drug and the slowing of biological aging.
An AI-designed drug candidate for lung disease, Rentosertib, has shown potential to reverse biological aging markers in early clinical data.